Avanos Medical (AVNS) Set to Announce Earnings on Thursday

Avanos Medical (NYSE:AVNS) is scheduled to be posting its quarterly earnings results on Thursday, May 2nd. Analysts expect Avanos Medical to post earnings of $0.21 per share for the quarter. Avanos Medical has set its FY24 guidance at $1.30-1.45 EPS.Investors interested in participating in the company’s conference call can do so using this link.

Avanos Medical (NYSE:AVNS) last released its quarterly earnings results on Tuesday, February 20th. The company reported $0.36 earnings per share for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.01). The company had revenue of $173.30 million during the quarter, compared to analysts’ expectations of $170.43 million. Avanos Medical had a positive return on equity of 4.25% and a negative net margin of 8.76%. The firm’s revenue was down 4.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.60 EPS. On average, analysts expect Avanos Medical to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Avanos Medical Stock Performance

AVNS traded up $0.26 on Friday, hitting $18.11. 7,421 shares of the company’s stock were exchanged, compared to its average volume of 276,243. The firm has a market cap of $836.68 million, a PE ratio of -13.72 and a beta of 0.96. The company has a current ratio of 2.08, a quick ratio of 1.38 and a debt-to-equity ratio of 0.13. The stock has a fifty day moving average of $19.26 and a two-hundred day moving average of $19.92. Avanos Medical has a twelve month low of $17.24 and a twelve month high of $30.28.

Analysts Set New Price Targets

Separately, StockNews.com upgraded Avanos Medical from a “hold” rating to a “buy” rating in a report on Tuesday, March 19th.

Insider Transactions at Avanos Medical

In other news, CFO Michael Greiner sold 8,000 shares of the firm’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $19.12, for a total transaction of $152,960.00. Following the sale, the chief financial officer now directly owns 151,495 shares in the company, valued at approximately $2,896,584.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 2.90% of the company’s stock.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.